
    
      1. This is a prospective blinded randomized multicenter comparison clinical trial followed
           the design of superiority trial to compare the effectiveness and safety of the guidewire
           for echo-guided interventions designed by Hangzhou Dexin Medical Technological Company
           with other similar products.

        2. This trial will enroll about 100 subjects from 3-5 centers. Patients will be randomized
           to two groups in equal proportion (50 in each). Proposal recruiting period is 18 months
           and follow-up will be performed for 30 days.
    
  